CMLVAX100 vaccine may reduce residual disease in CML

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1476, 2005-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NSAIDs may reduce the risk of Alzheimer's disease

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Mirtazapine may reduce nocturnal pruritus in patients with inflammatory skin disease

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The use of HAART and 23-valent conjugated pneumococcal vaccine may reduce the incidence of pneumococcal infections

Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Donepezil May Reduce Insulin-Like Growth Factor-1 (IGF-1) Levels in Alzheimer’s disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 108-112

Bentham Science Publishers

Access to resources Recommend Favorite

SNPs may reduce the efficacy of pravastatin

Inpharma, Vol. 1, Iss. 1443, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite